Skyhawk Therapeutics has announced that its investigational drug, SKY-0515, has met the eligibility criteria for provisional registration by Australia’s Therapeutic Goods Administration (TGA). This...
A recent study conducted by researchers at Northwestern Medicine has uncovered a significant connection between nucleotide metabolism and chromatin assembly, enhancing our understanding of...